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Nontypeable Haemophilus influenzae (NTHi) is an opportunistic pathogen that resides
in the upper respiratory tract and contributes to a significant burden of respiratory
related diseases in children and adults. Haemophilus haemolyticus is a respiratory tract
commensal that can be misidentified as NTHi due to high levels of genetic relatedness.
There are reports of invasive disease from H. haemolyticus, which further blurs the
species boundary with NTHi. To investigate differences in pathogenicity between these
species, we optimized an in vitro epithelial cell model to compare the interaction of 10
H. haemolyticus strains with 4 NTHi and 4 H. influenzae-like haemophili. There was
inter- and intra-species variability but overall, H. haemolyticus had reduced capacity
to attach to and invade nasopharyngeal and bronchoalveolar epithelial cell lines (D562
and A549) within 3 h when compared with NTHi. H. haemolyticus was cytotoxic to both
cell lines at 24 h, whereas NTHi was not. Nasopharyngeal epithelium challenged with
some H. haemolyticus strains released high levels of inflammatory mediators IL-6 and
IL-8, whereas NTHi did not elicit an inflammatory response despite higher levels of cell
association and invasion. Furthermore, peripheral blood mononuclear cells stimulated
with H. haemolyticus or NTHi released similar and high levels of IL-6, IL-8, IL-10,
IL-1β, and TNFα when compared with unstimulated cells but only NTHi elicited an IFNγ
response. Due to the relatedness of H. haemolyticus and NTHi, we hypothesized that
H. haemolyticus may compete with NTHi for colonization of the respiratory tract. We
observed that in vitro pre-treatment of epithelial cells with H. haemolyticus significantly
reduced NTHi attachment, suggesting interference or competition between the two
species is possible and warrants further investigation. In conclusion, H. haemolyticus
interacts differently with host cells compared to NTHi, with different immunostimulatory
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and cytotoxic properties. This study provides an in vitro model for further investigation
into the pathogenesis of Haemophilus species and the foundation for exploring whether
H. haemolyticus can be used to prevent NTHi disease.
Keywords: colonization, Haemophilus haemolyticus, host epithelium, inflammatory mediators, in vitro, NTHi,
PBMCs
INTRODUCTION
Haemophilus haemolyticus is a respiratory tract commensal that
is closely related to the opportunistic pathogen nontypeable
Haemophilus influenzae (NTHi). NTHi is a major cause of otitis
media (OM) in children (Murphy et al., 2009b; Wiertsema
et al., 2011) and exacerbations of chronic obstructive pulmonary
disease (COPD) in adults (Thanavala and Lugade, 2011;
Alikhan and Lee, 2014). Additionally, NTHi causes sinusitis,
conjunctivitis, pneumonia, bacteraemia and meningitis (Shann
et al., 1984; Dworkin et al., 2007; Cripps, 2010; Laupland et al.,
2011; van Wessel et al., 2011). The burden of invasive disease
due to NTHi is steadily increasing, particularly in infants and the
elderly (Laupland et al., 2011). There is added concern due to the
emergence of antibiotic resistance within the species (Van Eldere
et al., 2014). Although H. haemolyticus is generally considered
a commensal, there are occasional reports of isolation of this
bacterium from normally sterile sites (Anderson et al., 2012;
Morton et al., 2012; Hariadi et al., 2015). The distinction of H.
haemolyticus as a true commensal is complicated by the fact
that H. haemolyticus can be misidentified as NTHi using routine
microbiological tests (reviewed in Pickering et al., 2014b). Whilst
in-depth investigations into the genetics of H. haemolyticus and
NTHi have been conducted in order to develop discriminatory
tests to distinguish these closely related species (McCrea et al.,
2008, 2010a; Sandstedt et al., 2008; Norskov-Lauritsen, 2011;
Binks et al., 2012; Pickering et al., 2014b), the interaction of H.
haemolyticus with host cells has not been previously investigated.
Colonization of the human upper respiratory tract with
NTHi precedes infection and studies have shown an association
between a high density of NTHi carriage and subsequent
development of OM (Smith-Vaughan et al., 2006, 2013).
Although the progression from NTHi colonization to disease is
not entirely understood, in vitro and in vivo studies have revealed
that NTHi can persist in biofilms and/or intracellularly within the
respiratory tract (Murphy et al., 2009a; Clementi and Murphy,
2011; Novotny et al., 2013; Jalalvand and Riesbeck, 2014). This
makes NTHi respiratory infections such as OM difficult to treat
with antibiotics (Dagan, 2000). Current preventative strategies
against development of NTHi disease include the licensed
pneumococcal conjugate vaccine (PHID-CV) that incorporates
the NTHi lipoprotein Protein D (Prymula and Schuerman,
2009). PHiD-CV does not prevent NTHi colonization (van den
Abbreviations:A549, human lung carcinoma epithelial cells; CFU, colony forming
units; ChoP, phosphorylcholine; CTV, cell trace violet; D562, Detroit 562 human
pharyngeal carcinoma epithelial cells; IFN, interferon; IL, interleukin; LOS,
lipooligosaccharide, LPS, lipopolysaccharide; NTHi, nontypeable Haemophilus
influenzae; OM, otitis media; PBMCs, peripheral blood mononuclear cells; RT,
room temperature; SEB, Staphylococcus enterotoxin B; SEM, standard error of the
mean; TNF, tumor necrosis factor.
Bergh et al., 2013; Hammitt et al., 2014; Feazel et al., 2015)
and the impact of this vaccine on NTHi OM has been variable
(Prymula et al., 2011; van den Bergh et al., 2013; Tregnaghi
et al., 2014; Leach et al., 2015). Additionally, clinical Protein
D-negative NTHi strains have been identified (Smith-Vaughan
et al., 2014) highlighting the potential for PHID-CV evasion by
NTHi. Indeed, sub-unit vaccines against NTHi are limited given
the considerable antigenic variation within NTHi (Cripps et al.,
2002; Price et al., 2015). A Cochrane review of six clinical trials
with an oral whole-cell killed NTHi vaccine developed to reduce
acute exacerbations in COPD patients revealed mixed results and
studies that did show a benefit to COPD patients had too small
numbers to warrant widespread vaccination (Teo et al., 2014).
An alternative approach to vaccination is the use of probiotic
therapies with the potential to modulate the host microbiome
and prevent infection. Data from trials of probiotics to prevent
OM are conflicting with some studies showing protection
(Skovbjerg et al., 2009; Lehtoranta et al., 2012; Di Pierro et al.,
2014) and others demonstrating a lesser or no impact (Taipale
et al., 2011; Cohen et al., 2013). To our knowledge, no studies
have directly addressed the prevention of NTHi colonization
with a commensal or probiotic species. We propose that H.
haemolyticus may interfere with NTHi colonization of the
respiratory tract and could therefore be exploited as a probiotic
to reduce the burden of NTHi disease. This is not only due to
the fact that both species colonize the respiratory tract and are
highly related at a genomic level (Price et al., 2015) but also that
H. haemolyticus is less often isolated from populations with high
rates of NTHi carriage and disease (Fenger et al., 2012; Pickering
et al., 2014c; Aho et al., unpublished). In order to explore the
potential therapeutic use of H. haemolyticus, investigations into
the interaction of H. haemolyticus with the host were required.
In this study, we used an established in vitro model of NTHi
infection (Swords et al., 2000) to characterize H. haemolyticus
association and invasion of human respiratory epithelial cells.
As H. haemolyticus is generally considered to be a commensal,
we hypothesized that nasopharyngeal H. haemolyticus isolates
would be able to colonize host epithelial cells but not necessarily
invade them like NTHi. To take into consideration the high
level of strain variation, we compared host cell association
and invasion of 10 H. haemolyticus isolates (including four
naturally occurring Protein D-negative isolates and an invasive
H. haemolyticus isolate) with four NTHi strains. We also assessed
four representative isolates from a clade of “fuzzy” haemophili
that have recently been differentiated from NTHi and H.
haemolyticus by whole genome sequencing and are referred to as
“H. influenzae-like haemophili” (Price et al., 2015). Inflammatory
responses from epithelial cells challenged with these strains
were evaluated and further assessed using peripheral blood
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mononuclear cells (PBMCs). Finally, we investigated whether
pre-treatment of epithelial cells withH. haemolyticus could block
NTHi attachment to cells to determine whether H. haemolyticus
can inhibit NTHi colonization. This is the first study to assess
in vitro interactions ofH. haemolyticus with host cells. This study
provides in vitro models to further investigate the pathogenesis
of haemophili, the biological role of H. haemolyticus, and to
determine whetherH. haemolyticusmay be used to prevent NTHi
colonization and therefore disease.
MATERIALS AND METHODS
Microbial Strains and Growth Conditions
The isolates assessed in this study were first described in
four previous studies (Bakaletz et al., 1988; Nizet et al., 1996;
Wiertsema et al., 2011; Morton et al., 2012) and are detailed in
Table 1. All isolates were X and V factor dependent and were
identified as either NTHi, H. haemolyticus or H. influenzae-like
haemophili by hpd#3 PCR (Wang et al., 2011), HRM hpd PCR
(Pickering et al., 2014a), fucP PCR, or whole genome sequencing
(Price et al., 2015).
Bacteria were cultured from glycerol stocks, or resuspended
lyophilised pellets, onto chocolate agar plates and incubated
TABLE 1 | Haemophilus isolates assessed in this study.
Isolate ID Site of isolation Origin (study reference) PCRb
NTHi
86-028NP Nasopharynx U.S.A.; Bakaletz et al., 1988 hpd#3+, fucP+
R2866 Blood U.S.A.; Nizet et al., 1996 hpd#3+, fucP+
H76 Middle ear W.A.; Wiertsema et al., 2011 hpd#3+, fucP+
H94 Nasopharynxa W.A.; Wiertsema et al., 2011 hpd#3+, fucP+
H. haemolyticus
Hh33390 Sputum ATCC® 33390TM hpd#3−, fucP−
HI2028 Blood U.S.A.; Morton et al., 2012 hpd#3−, fucP−
H12 Nasopharynx W.A.; Wiertsema et al., 2011 hpd#3−, fucP−
H19c Nasopharynx W.A.; Wiertsema et al., 2011 hpd#3−, fucP−
H34 Nasopharynx W.A.; Wiertsema et al., 2011 hpd#3−, fucP−
H51c Nasopharynx W.A.; Wiertsema et al., 2011 hpd#3−, fucP−
H54c Nasopharynx W.A.; Wiertsema et al., 2011 hpd#3−, fucP−
H56c Nasopharynx W.A.; Wiertsema et al., 2011 hpd#3−, fucP−
H95 Nasopharynxa W.A.; Wiertsema et al., 2011 hpd#3−, fucP−
H152 Nasopharynx W.A.; Wiertsema et al., 2011 hpd#3−, fucP−
H. influenzae—like (designated according to phylogenetic
tree in Price et al., 2015)
H18 Nasopharynx W.A.; Wiertsema et al., 2011 hpd#3+, fucP−
H40 Nasopharynx W.A.; Wiertsema et al., 2011 hpd#3+, fucP−
H148 Middle ear W.A.; Wiertsema et al., 2011 hpd#3+, fucP−
H180 Nasopharynx W.A.; Wiertsema et al., 2011 hpd#3+, fucP−
a isolated from the same nasopharyngeal swab.
bThe hpd#3 PCR is NTHi-specific (Wang et al., 2011) and therefore does not detect H.
haemolyticus hpd.
chpd-negative H. haemolyticus confirmed by PCR (Pickering et al., 2014a) and whole
genome sequencing (Price et al., 2015).
ATCC, American Type Culture Collection; U.S.A, United States of America; W.A. Western
Australia.
overnight at 37◦C in 5% CO2. Inoculum for all subsequent
experiments was harvested from agar plates as previously
described for NTHi (Swords et al., 2000). Bacterial viability was
measured as previously described (Kirkham et al., 2013).
Epithelial Cell Culture and Viability
All cell culture reagents were from Gibco, Life Technologies,
Tullamarine, Victoria, Australia, unless otherwise stated. Cell
cultures were maintained in 125 cm3 flasks (BD Biosciences,
Macquarie Park, NSW, Australia) at 37◦C, 5% CO2.Immortalized
Detroit 562 human pharyngeal carcinoma epithelial cells
(ATCC R© CCL-138) were cultured in Minimal Essential Media
(MEM) with Earle’s salts and supplemented with 10% heat
inactivated fetal calf serum (Sigma-Aldrich), 1mM sodium
pyruvate, 2mM L-glutamine, 1 × non-essential amino acids,
and 100 U Penicillin/Streptomycin. Cells were weaned from
antibiotics 24 h prior to suspension in 24-well tissue culture plates
(Corning, Life Technologies). Immortalized A549 human lung
carcinoma epithelial cells (ATCC R© CCL-185) were cultured in
RPMI 1640 (Invitrogen, Life Technologies) supplemented with
10% heat inactivated fetal calf serum. At confluence, flasks of each
cell line were disrupted with 0.05% trypsin/EDTA, washed in 1×
PBS and resuspended in their respective culturemedia. Cells were
counted with a haemocytometer and viability was determined by
trypan blue staining. Then cells were seeded into 24-well plates at
1× 105/mL and grown to confluence for bacterial challenge.
Bacterial Association and Invasion of
Respiratory Epithelial Cell Lines
A standard gentamicin invasion assay was used to determine
the ability of H. haemolyticus and NTHi to attach to and
invade epithelial cells (Swords et al., 2000), with the following
modifications. Monolayers of cells were challenged at a
multiplicity of infection (MOI) of 10:1 bacteria:cells for 1, 3,
or 24 h. At the 1 h gentamicin treatment step for evaluation of
intracellular bacteria, media only was added to the cells being
evaluated for total bacterial association for 1 h. 100µg/mL of
gentamicin was used instead of 50µg/mL. All isolates were
checked to be sensitive to 100µg/mL gentamicin and resistant
to 2% saponin as determined by viable count. Assays were
conducted in triplicate and on at least three separate occasions.
Supernatants from each triplicate well were pooled after bacterial
challenge, filter-sterilized and stored at −80◦C for measurement
of inflammatory mediators.
PBMC Stimulation with Bacteria
Adult PBMCs were collected from five healthy donors and
processed and prepared as previously described (Kirkham
et al., 2013). PBMCs were stimulated with thawed preparations
of either NTHi86-028NP or H. haemolyticus33390 at 10:1
bacteria:cells. Cells in control wells were treated with either
PBS (cells only; unstimulated), 1 ng/mL lipopolysaccharide
(LPS, from Escherichia coli R515; Alexis Biochemicals, Sapphire
Biosciences, NSW, Australia) or 1µg/mL Staphylococcal
enterotoxin B (SEB, from Staphylococcus aureus; Sigma Aldrich).
At 24 h post-treatment, plates were centrifuged for 5min at
200 g and supernatants were harvested. Triplicate wells were
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combined and stored at -80◦C for measurement of inflammatory
mediators.
Cytokine and Chemokine Analysis
IL-6, IL-10, IFNγ, and TNFα levels (pg/mL) were measured in
filter-sterilized supernatants from epithelial and PBMC cultures
using the Bioplex 200 system (Bio-Rad Laboratories Inc.,
Hercules, CA, USA) and an in-house multiplex bead-based assay
as previously described (Blyth et al., 2011). Measurement of IL-
1β and IL-8 was added into this Bioplex assay using commercially
available antibody pairs (Bioscientific, Kirrawee, NSW, Australia)
and following validation to ensure that there was no cross
reactivity with any of the other cytokines.
Staining and Flow Cytometry
As NTHi is difficult to distinguish from H. haemolyticus by
standard microbiological culture, we used the fluorescent dye
Cell Trace Violet (CTV, excitation= 390 nm, emission= 445 nm;
Invitrogen) to label NTHi86-028NP for experiments involving
bacterial co-culture. Overnight growth of bacteria was harvested
from chocolate agar plates and resuspended in cell culture media
to an OD600nm 0.2 (which is equivalent to ∼10
8 CFU/mL).
Bacterial suspensions were incubated with 20µMCTV for 5min
before pelleting at maximum speed in a benchtop centrifuge for
7min. Harvested bacteria were resuspended in 10mL of pre-
warmed epithelial cell culture media, protected from light and
incubated at 37◦C for 10min before use. The CTV stain did
not affect the ability of NTHi86-028NP to attach to or invade
A549 cells (data not shown). Flow cytometry was conducted on
a Flow and cell cytometer Canto II device (BD Biosciences) that
was calibrated using Cytometer Setup and Tracking beads (BD
Biosciences). Forward scatter and side scatter were set to capture
bacterial populations. Flow cytometry data was acquired using
FACSDiva software and then analyzed using Flow Jo v7 software
(FloJo LLC, Oregon, USA).
Competitive Colonization Assay with
Detroit 562 Cells
The optimal challenge dose of ∼1 × 107 CFU/mL for the
association and invasion experiments was not possible for the
competitive colonization experiment due to the high background
fluorescence of unstained bacteria. We therefore used a higher
challenge dose of 1 × 109 CFU/mL CTV-NTHi (MOI 1000:1).
NTHi86-028NP was prepared and stained as above however the
bacterial suspension was concentrated to 1 × 109 CFU/mL by
harvesting 100mL and resuspending in 10mL prior to addition
to epithelial cells. Overnight growth of H. haemolyticus33390
was harvested from chocolate agar plates and resuspended in
cell culture media to an OD600 nm 0.2 (which is equivalent
to ∼108 CFU/mL). D562 monolayers were treated with either
10-fold increasing doses (1 × 103 to 1 × 107 CFU/mL) of H.
haemolyticus33390 or media alone for 1 h at 37◦C, 5% CO2. Cells
were then washed three times with PBS to remove unbound
H. haemolyticus and challenged with 1 × 109 CFU/mL CTV-
labeled NTHi86-028NP in culture media for 1 h. Two control
wells were treated with 1 × 109 CFU/mL unstained NTHi to
give background fluorescence levels. All wells were washed three
times with 200µL PBS to remove unbound NTHi and then
200µL of PBS was aliquoted into each well. Each plate was then
read immediately with an Enspire plate reader (Perkin Elmer,
Massachusetts, USA).
Transwell Assay with A549 Cells
High density 3µM pore Transwell inserts (BD Biosciences)
were seeded with 1 × 104 A549 cells and cultured until
confluent. As the high density inserts are opaque, it was not
possible to gauge confluence of the cells on these inserts
with a microscope. Therefore, two transparent low density
3µM pore inserts were used to gauge confluence of A549
monolayers on the high density inserts. Transepithelial electrical
resistance (TER) measurements were variable with A549 cells,
therefore fluorescently conjugated dextrans RITC (Rhodamine
B Isothiocyanate conjugated to 70 kDa dextran) and FITC
(Fluoroscein Isothiocyanate conjugated to 3 kDa dextran; both
Sigma) were used to determine the permeability of confluent
epithelial cells seeded onto Transwells, as previously described
(Kowapradit et al., 2010). The concentration of each fluorescent
tracer was measured by the Enspire multi plate reader (FITC
excitation = 485 nm, emission = 544 nm, RITC excitation =
520 nm, emission = 590 nm) using standard curves of known
concentrations of RITC and FITC. Epithelial monolayers that
were deemed confluent by microscopy were confirmed to be
exclusive of passive bacterial transfer by the presence of 3 kDa
but not 70 kDa fluorescent tracers in the lower compartment of
the Transwell cultures.
When the low density inserts were deemed confluent with
A549 cells, cells were counted from these two inserts and the
average cell count was used to determine the bacterial challenge
dose required for an MOI of 10:1. Media was removed from
the inner chamber of the Transwell inserts and replaced with
either media alone or media containing H. haemolyticus (MOI
10:1), prepared as described above for the bacterial association
experiments. Treated cells were incubated at 37◦C, 5% CO2 for
1 h. Inserts were then washed thoroughly with PBS, and CTV-
stained NTHi (MOI of 10:1) was added to the inner chambers.
Following a 3 h incubation at 37◦C, 5% CO2, 100µL of media
from above and 100µL of media from below the Transwells was
removed for FACs analysis.
Statistical Analyses
Statistical analyses were conducted using GraphPad Prism
version 5.02 (GraphPad Inc., California, USA) and p < 0.05 was
considered statistically significant. Student’s t-tests were used to
compare log transformed bacterial viability and Mann-Whitney
U-tests were used to compare epithelial viability and bacterial
association and invasion of individual isolates with reference
strains. Kruskal-Wallis test with Dunn’s post-test analysis was
used to compare intra-species association and invasion of
epithelial cells, epithelial cytokine release and PBMC cytokine
release. Student’s t-tests were used to determine differences
in bacterial fluorescence following different pre-treatments in
competitive colonization assays.
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FIGURE 1 | Viability of respiratory epithelial cells co-cultured with H. haemolyticus and NTHi. Viability of NTHi86-028NP and H. haemolyticus33390 in D562
(A) and A549 (B) cell culture media (no epithelial cells) over 24 h as determined by viable count.Viability of D562 (C) and A549 (D) respiratory epithelial cells incubated
with media only (circles), H. haemolyticus33390 (squares), or NTHi86-028NP (triangles) over 24 h as determined by trypan blue counts. Student’s t-tests were used to
compare log transformed bacterial viability and Mann Whitney U-tests were used to compare post bacterial challenge epithelial cell viability, where *p < 0.05,
**p < 0.01, ***p < 0.001.
RESULTS
H. haemolyticus Viability in Cell Culture
Media Diminished Significantly More than
NTHi
The viability of reference strains H. haemolyticus33390 and
NTHi86-028NP remained relatively stable in D562 and A549
media for the first 3 h of incubation. However, by 24 h the viability
of H. haemolyticus33390 dropped significantly in D562 media
(Figure 1A, p < 0.001) and A549 media (Figure 1B, p < 0.05)
when compared to NTHi viability at 24 h.
H. haemolyticus was Cytotoxic,
Particularly to A549 Epithelial Cells
H. haemolyticus33390 challenge had no impact on D562 cell
viability at 3 h, however the epithelial viability reduced to 50%
by 24 h (Figure 1C). This cell death was even more pronounced
with A549 cells, where viability following H. haemolyticus33390
challenge decreased from ∼85% at 3 h to complete cell death at
24 h (Figure 1D). In contrast, NTHi had minimal impact on the
viability of both cell lines over the same time period. Several H.
haemolyticus isolates were also cytotoxic at 24 h (data not shown).
In consideration of the viability results, a 3 h time point and D562
cells were chosen for further analysis of H. haemolyticus host cell
association, invasion, and inflammatory properties.
H. haemolyticus Associated with Epithelial
Cells but Not As Well As NTHi
There was significant intra-species variability in the capacity
of each haemophilus group to attach to and invade D562
cells (Figures 2A,B; p < 0.01). However, overall the NTHi
isolates displayed a greater ability to associate with and invade
D562 epithelia (range: association 76–122%, invasion 44–79%)
compared with H. haemolyticus isolates (range: association
48–93%, invasion 0–70%) and H. influenzae-like isolates
(range: association 49–101%, invasion 0–62%) (Figures 2A,B).
The invasive H. haemolyticus isolate HI2028 and invasive
H. influenzae-like middle ear isolate H148 had high levels of
attachment (96 ± 1% and 99 ± 1%, respectively, Figure 2A) and
invasion (58 ± 1% and 58 ± 1%, respectively, Figure 2B) that
were comparable to the NTHi strains and significantly higher
than the H. haemolyticus33390 reference strain (p < 0.01).
However, this was not specific to the invasive H. haemolyticus
strain as there were also carriage isolates ofH. haemolyticus (H12,
H54, H95) that had attachment and invasion properties similar to
NTHi.
Protein D is Not Essential for H.
haemolyticus Association with Host Cells
The absence of the protein D (hpd) gene in four clinical
H. haemolyticus isolates (H19, H51, H54, and H56) was
confirmed by whole genome sequencing (Price et al., 2015).
Based on previous NTHi data, we hypothesized that the
H. haemolyticus hpd-negative isolates would have significantly
reduced association with host cells. This was not observed, with
the four strains displaying significant variability in attachment
(p < 0.01) and invasion (p < 0.01), Figures 2A,B. Compared
with the H. haemolyticus33390 reference strain, two of the
hpd-negative H. haemolyticus isolates (H19, H56) had similar
association properties (p = 0.75 and p = 0.44, respectively)
and 2 (H51, H54) had significantly higher association properties
(p < 0.01 and p < 0.01, respectively).
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FIGURE 2 | Interactions of clinical strains of haemophili with respiratory epithelia. Association (A) and invasion (B) of D562 epithelial monolayers with
haemophilus reference strains and clinical isolates at 3 h. Level of IL-6 (C) and IL-8 (D) present in cell culture supernatant at 3 h post-bacterial challenge and
presented as the fold change of cytokine in the supernatant from cells incubated with media only. Results are represented as the mean ± SEM of three separate
experiments, each conducted in triplicate excluding R2866 which was conducted once in triplicate. Kruskal-Wallis and Dunn’s post-test was used to compare
intra-species variability where **p < 0.01; ***p < 0.001.
Some H. haemolyticus Isolates Induced
High Pro-Inflammatory Responses from
Epithelial Cells whereas NTHi Did Not
There was significant variation in epithelial release of IL6
(p < 0.01, Figure 2C) and IL-8 (p < 0.01, Figure 2D)
in response to challenge with the 10 H. haemolyticus isolates
investigated. In contrast, there was negligible variability in
the IL-6 and IL-8 cellular responses to the different NTHi
strains (p = 0.35 and p = 0.77, respectively). The D562
IL-6 and IL-8 responses to NTHi challenge were lower than
those produced by unstimulated D562 cells. The invasive H.
haemolyticus HI2028 isolate behaved like NTHi in terms of
eliciting low levels of IL-6 and IL-8 compared with other H.
haemolyticus strains but this was not unique to the invasive
strain. Similarly, the H. influenzae-like middle ear isolate H148
lacked inflammatory properties compared to the other H.
influenzae-like strains, which matched the increased association
and invasion profile for the H148 strain. Strain H54, an hpd-
negative isolate, was the most immunostimulatory of all strains
assessed, but this high IL-6 and IL-8 response was not observed
for the other hpd-negative isolates (H19, H51, and H56). IFNγ,
TNFα, IL-10, and IL-1β measurements were below the limit of
detection in culture supernatant at the 3 h time-point (data not
shown).
NTHi-Treatment of PBMCs Elicited IFNγ
Production whereas H.
haemolyticus-Treatment Did Not
Extracellular levels of IL-6, IL-10, TNFα, and IL-1β were
significantly increased following 24 h stimulation of PBMCs with
either NTHi86-028NP (p < 0.01) or H. haemolyticus33390
(p < 0.05) when compared to unstimulated cells (Figure 3).
H. haemolyticus and LPS induced significant release of IL-8
from PBMCs compared with unstimulated cells (p < 0.01 and
p < 0.05, respectively). IL-8 production from PBMCs was
also elevated in response to NTHi but this was not significant.
In contrast, NTHi and SEB induced significant release of
IFNγ from PBMCs (p < 0.01 and p < 0.05, respectively)
whereas H. haemolyticus did not. There was minimal IFNγ
released from PBMCs treated with H. haemolyticus (mean
28 ± 10 pg/mL) compared with NTHi (mean 1718 ± 560
pg/mL).
Pre-Treatment of Epithelial Cells with H.
haemolyticus Inhibited NTHi Association
and Transcytosis
Incubation of D562 cells for 1 h with increasing doses of
H. haemolyticus33390 resulted in a significant reduction
in the subsequent association of CTV-labeled NTHi86-
028NP (Figure 4A). The greatest reduction of NTHi
association was observed when D562 cells were pre-
incubated with the lowest H. haemolyticus dose (MOI 1:1,
p < 0.0001).
A Transwell chamber assay was used to examine the ability
of H. haemolyticus to block NTHi transcytosis through a
monolayer of A549 epithelial cells (Figures 4B–E). We observed
that pre-treatment of Transwell cultured A549 cells with H.
haemolyticus33390 (MOI 10:1,∼1×107 CFU/mL) reducedNTHi
transcytosis by 30-fold (Figure 4E) when compared with cells
treated with NTHi alone (Figure 4C); 0.3 vs. 9% fluorescence.
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FIGURE 3 | Inflammatory mediator release (pg/mL) from PBMCs at 24h post-treatment with NTHi or H. haemolyticus. Concentration of inflammatory
mediators IL-6 (A), IL-8 (B), IL-10 (C), TNFα (D), INFγ (E), and IL-1β (F) following treatment of adult PBMCs with either media alone (unstim), lipopolysaccharide
(LPS), Staphylococcal enterotoxin B (SEB), NTHi86-028NP, or H. haemolyticus33390. The horizontal bars depict the median analyte level for each treatment group
(n = 5). *p < 0.05, **p < 0.01; ***p < 0.001 when compared with unstimulated cells using a Kruskal-Wallis and Dunn’s post-test.
DISCUSSION
To our knowledge, this is the first study to assess interactions
of H. haemolyticus with host cells. We have developed in vitro
models that can be used to further investigate the interaction
of H. haemolyticus with the host. The loss in H. haemolyticus
viability in cell culture media over 24 h indicates bacterial death
but the mechanisms behind this (i.e., autolysis or allolysis) have
not been determined. We observed that, in contrast to NTHi,
H. haemolyticus is cytotoxic to immortalized nasopharyngeal
and bronchoalveolar epithelial cell lines over a 24 h incubation
period. This was surprising given the predominantly commensal
nature of H. haemolyticus. As H. haemolyticus does not grow
well in liquid media, it is possible that bacterial death results
in release of cytotoxic components over 24 h. Indeed, filtered
cell culture media from some H. haemolyticus strains incubated
for 24 h with D562 cells was cytotoxic to the immortalized
epithelial cell lines (data not shown), suggesting that a soluble
cytotoxic component is released into the cell culture media.
It is possible that some H. haemolyticus strains express a
toxin that is not expressed by NTHi. Indeed, H. ducreyi is
known to secrete cytolethal distending toxin, which arrests the
epithelial cell cycle (Gargi et al., 2013). Comparative genomics
has revealed putative H. haemolyticus toxins that are under
further investigation in our laboratory. It is also possible that our
method for preparing inoculum (harvesting bacteria from agar
plates rather than liquid culture) results in a high proportion of
dead bacteria that are not accounted for by viability counting.
These dead bacteria may lead to an increase in toxic load to
the epithelial cells, possibly from lipooligosaccharide (LOS) or
other toxins. However, the H. haemolyticus and NTHi inocula
were prepared in the same manner and the NTHi preparation
was not cytotoxic. Differences in the phosphorylcholine (ChoP)
decoration of LOS betweenH. haemolyticus and NTHi have been
identified and have been suggested to provide an explanation for
NTHi pathogenesis through promotion of bacterial adherence
and invasion of host cells (McCrea et al., 2010b; Post et al.,
2016). Detailed comparison of LOS structures from nine H.
haemolyticus and six NTHi strains found that only 4/9 (44%)
of the H. haemolyticus strains tested expressed ChoP decorated
LOS in comparison with 5/6 of NTHi strains (Post et al., 2016).
Interestingly, we found that a similar proportion of the H.
haemolyticus strains in our study (4/10) had better attachment
to epithelial cells that was similar to the NTHi strains (>80%
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 May 2016 | Volume 6 | Article 50
Pickering et al. Haemophilus haemolyticus Host Interactions
FIGURE 4 | Pre-colonization of epithelia with H. haemolyticus impacts subsequent NTHi interactions. Monolayers of D562 cells were challenged with
increasing doses of H. haemolyticus33390 or media for 1 h, washed thoroughly and then challenged with 1000:1 CTV-stained NTHi86-028NP (A). At 1 h post
NTHi-infection, wells were thoroughly washed, and fluorescence was measured to identify attached NTHi. Results are represented as mean ± SEM of three technical
repeats. Student’s unpaired t-test was used to compare between treatments where **p < 0.01, ***p < 0.001. A549 monolayers grown on Transwells were incubated
with media (B,C) or 10:1 H. haemolyticus33390 (D,E) for 1 h. Monolayers were then washed with media, challenged with CTV-stained NTHi (MOI 10:1) and incubated
at 37◦C 5% CO2 for a further 3 h. Pre-colonization with H. haemolyticus (MOI 10:1) reduced the proportion of CTV-stained NTHi detected in the lower compartment
of the Transwell (E, 0.3%) compared with pre-incubation with media alone (C, 9.0%).
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association of challenge inoculum; Figure 1). Whether ChoP
decoration of LOS facilitates H. haemolyticus association with
epithelial cells remains to be determined. It is important to
understand the basis of the observed cytotoxicity and intra-
species variation if H. haemolyticus is to be further assessed
as a potential probiotic. Identification of virulence genes and
recombination hotspots inH. haemolyticus will highlight regions
that will require attenuation or natural selection.
Our hypothesis was that H. haemolyticus would not associate
with and/or invade epithelial cells in the same capacity as NTHi.
All 10 H. haemolyticus strains investigated were able to infect
cells within 3 h (with most association and invasion occurring
in the first hour). Although H. haemolyticus was hypothesized to
have reduced cell association and invasion overall compared with
NTHi, there was considerable intra-species variation. Such strain
to strain variation was expected, given how closely related H.
haemolyticus is to the genetically heterologous NTHi (Erwin and
Smith, 2007; Price et al., 2015) and the ability for recombination
between these species (Sondergaard et al., 2014). The greatest
difference between H. haemolyticus and NTHi attachment and
invasion was evident between the reference strains, highlighting
the necessity for assessingmultiple strains within a species to gain
an understanding of strain diversity.
Protein D, the NTHi vaccine antigen in PHiD-CV, has been
demonstrated to be important for adherence of NTHi to airway
epithelial cells (Johnson et al., 2011). In contrast, Protein D
does not appear to be required for H. haemolyticus association
with host cells, with the four different Protein D-negative strains
exhibiting higher or equal attachment to and invasion of cells
than Protein D-positive strains. A protein D knockout in H.
haemolyticus would need to be constructed and compared with
the parent strain to confirm that Protein D is not essential for
H. haemolyticus adherence to epithelial cells. The identification
of naturally-occurring Protein D-negative NTHi carriage isolates
(Smith-Vaughan et al., 2014) also suggests that this vaccine
antigen is not required for NTHi colonization of the host.
The invasive H. haemolyticus isolate HI2028 (Morton et al.,
2012) interacted with the host cells in a similar manner to the
NTHi isolates, with comparable cell association, invasion, and
low inflammatory responses. However, this was not exclusive to
HI2028 and other non-invasive H. haemolyticus carriage isolates
displayed similar host interactions. Comparative genomics of the
virulome for HI2028 vs. other haemophili may provide insight
into whether there are specific genes (possibly acquired from
NTHi) that are required for H. haemolyticus to become invasive.
We also assessed the host-cell interactions of four strains
that belong to a recently described clade of “H. influenzae-like”
haemophili (Price et al., 2015). These strains are identified as
NTHi by the #hpd3 PCR (Wang et al., 2011) but are lacking
the fucose operon that is used to identify NTHi with the multi-
locus sequence typing scheme (http://haemophilus.mlst.net/; de
Gier et al., 2015; Price et al., 2015). Overall, the H. influenzae-
like haemophili were more similar in their host cell interactions
to the H. haemolyticus than the NTHi strains assessed in this
study, with lower attachment and invasion of epithelial cells
and higher immunostimulatory properties. Interestingly, the one
H. influenzae-like strain that displayed NTHi-like properties
(H148) was isolated from the middle ear effusion of a child
with recurrent acute OM whereas the other H. influenzae-like
strains were nasopharyngeal isolates. The intra- and inter-species
variability in host interactions that were observed in this study
highlights the complexity of species definition in the genomic era.
Awareness of the H. influenzae-like cluster and further analysis
of the phenotypic traits of such strains is required to assist in
resolving Haemophilus speciation.
H. haemolyticus was overall more immunostimulatory to
epithelial cells than NTHi, with negligible release of IL-8 and
IL-6 at 3 h post-NTHi stimulation. This suggests that NTHi is
able to down-regulate or evade the initial immune responses
in this model. The majority of the literature on host epithelial
responses to NTHi are either with bacterial lysates or purified
bacterial components rather than live NTHi. In support of
our findings, assessment of A549 epithelial cell inflammatory
responses to NTHi found that live NTHi did not stimulate
activation of the IL-8 promoter, whereas treatment of the A549
cells with a soluble cytoplasmic fraction of NTHi induced
robust IL-8 promoter activation within 4 h (Wang et al., 2003).
This is further supported in a study describing NTHi isolates
that did not stimulate mRNA expression of any cytokine or
chemokine in human middle ear epithelial cells (Tong et al.,
2001). The mechanisms for NTHi evasion of the host epithelial
inflammatory response are not fully understood but it appears
that some strains of H. haemolyticus also possess this property.
Interestingly, gut commensals have been shown to either
attenuate host production of inflammatory cytokines (Neish
et al., 2000) or elicit a local inflammatory response (Chervonsky,
2012) to regulate colonization. It is possible that H. haemolyticus
may use similar methods for regulating colonization of the
respiratory tract. The host response to polymicrobial challenge
has not been taken into consideration in our study and the
synergistic effect of NTHi and H. haemolyticus, as well as other
respiratory flora, warrants investigation. For example, there is
an increase in IL-8 production from A549 and D562 cells when
they are simultaneously challenged with NTHi and Streptococcus
pneumoniae, compared with single species challenge (Ratner
et al., 2005). Understanding regulation of microbial colonization
at the epithelial surface may lead to the development of strategies
to promote healthy colonization of the human respiratory tract
and ultimately to the prevention of respiratory tract infections.
Further differences in cell-mediated responses to NTHi andH.
haemolyticus were observed with PBMCs, where NTHi86-028NP
challenge released high levels of IFNγ but H. haemolyticus33390
did not. IFNγ is critical in clearing intracellular bacterial
infections such as Listeria monocytogenes and Salmonella
typhimurium (Suzue et al., 2003). Intracellular survival provides
a reservoir of bacteria for reinfection and is thought to contribute
to the recurrent nature of diseases such as OM and exacerbations
in bronchiectasis patients (Coates et al., 2008; King et al., 2008).
We have shown that NTHi can persist intracellularly in the
middle ear of children with recurrent OM (Thornton et al., 2011).
Although a specific role for IFNγ in clearing NTHi infection
has not been identified, PBMCs from children with chronic
suppurative lung disease (Pizzutto et al., 2015) and adults with
bronchiectasis (King et al., 2008) have been shown to have
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impaired IFNγ production in response to NTHi challenge. The
lack of IFNγ response from H. haemolyticus treated PBMCs may
suggest that H. haemolyticus cannot survive inside PBMCs or
it may just be that the H. haemolyticus has died in cell culture
media (as observed with the epithelial cell culture media by
24 h). Indeed, we have previously shown that live preparations
of NTHi (instead of heat-killed or ethanol-killed) are required
for IFNγ production from PBMCs (Kirkham et al., 2013). A
limitation of this study is that bacterial viability was not assessed
due to the difficulty in distinguishing a loss in bacterial viability
from cell-mediated killing. There was significantly more IL-
8 production from H. haemolyticus treated PBMCs compared
with NTHi-challenge, whether this is due to release of a
soluble factor from live or dead H. haemolyticus remains to be
determined.
Pre-treatment of D562 monolayers with all doses of H.
haemolyticus reduced the proportion of NTHi that were
subsequently able to associate with the epithelial cells. The lowest
dose of H. haemolyticus (MOI 1:1) resulted in the greatest
reduction of NTHi association, suggesting that the inhibitory
effect of H. haemolyticus on NTHi attachment may be more
than just competition for binding sites. These data, together
with the immunostimulatory capacity ofH. haemolyticus, suggest
that immune activation may have a role in prevention of NTHi
attachment and subsequent invasion. It is important to note
that NTHi attachment was inhibited by H. haemolyticus, despite
needing to use a high NTHi challenge dose (1 × 109 CFU/mL)
to detect fluorescence above background levels for unstained
NTHi. In attempts to improve sensitivity for assessment of
whether H. haemolyticus could block NTHi association and
infection, a Transwell assay was investigated. We observed
that pre-colonization of A549 monolayers with H. haemolyticus
reduced the proportion of NTHi that could translocate through
the epithelial cells. Whilst this result was also promising, the
Transwell model we employed has limitations and others have
suggested A549 cells do not express functional tight junction
proteins when grown as a monolayer (Balis et al., 1984; Winton
et al., 1998). This is likely to have an impact on the integrity of
the epithelial barrier, and suggests that more complex models are
required to investigate the potential ofH. haemolyticus to prevent
NTHi association and invasion.
In summary, we have demonstrated that the interaction of
H. haemolyticus with the host is fundamentally different to
NTHi, despite their genetic similarity and ability to recombine.
We have indicated that the H. influenzae-like cluster of NTHi
strains interact with the host in a more similar manner to H.
haemolyticus than NTHi, in terms of epithelial association and
cytokine responses. Our data suggest that H. haemolyticus may
block NTHi colonization, providing the foundation for further
assessment of H. haemolyticus as a bacterial therapy to prevent
NTHi diseases.
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